Daniel Calarese
Executive Director, Research Innovation Sutro Biopharma
Seminars
Monday 3rd November 2025
Showcasing Development of Site-Specific, High-DAR Dual-Payload ADCs
11:30 am
- Addressing the clinical challenge of acquired resistance to single-payload ADCs by delivering two different payloads simultaneously to tumors
- Utilizing an innovative cell-free platform to create novel dual payload conjugates
- Showcasing dual-payload ADC approaches with superior preclinical in vitro and in vivo efficacy data
